Suzanne Fraser

5.7k total citations
153 papers, 3.9k citations indexed

About

Suzanne Fraser is a scholar working on Epidemiology, General Health Professions and Clinical Psychology. According to data from OpenAlex, Suzanne Fraser has authored 153 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Epidemiology, 49 papers in General Health Professions and 32 papers in Clinical Psychology. Recurrent topics in Suzanne Fraser's work include HIV, Drug Use, Sexual Risk (66 papers), Substance Abuse Treatment and Outcomes (31 papers) and Mental Health and Patient Involvement (22 papers). Suzanne Fraser is often cited by papers focused on HIV, Drug Use, Sexual Risk (66 papers), Substance Abuse Treatment and Outcomes (31 papers) and Mental Health and Patient Involvement (22 papers). Suzanne Fraser collaborates with scholars based in Australia, Czechia and United Kingdom. Suzanne Fraser's co-authors include David Moore, Carla Treloar, kylie valentine, Kate Seear, Adrian Farrugia, Robyn Dwyer, Renae Fomiatti, Helen Keane, JaneMaree Maher and Kiran Pienaar and has published in prestigious journals such as Social Science & Medicine, British Journal of Ophthalmology and Drug and Alcohol Dependence.

In The Last Decade

Suzanne Fraser

149 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne Fraser Australia 36 2.0k 1.4k 946 939 730 153 3.9k
Neil McKeganey United Kingdom 31 1.7k 0.8× 1.1k 0.8× 1.0k 1.1× 672 0.7× 787 1.1× 155 3.5k
Joanne Neale United Kingdom 39 2.2k 1.1× 1.9k 1.4× 707 0.7× 1.4k 1.5× 616 0.8× 182 4.6k
Faye S. Taxman United States 37 1.7k 0.8× 1.9k 1.4× 3.0k 3.2× 573 0.6× 2.4k 3.3× 253 5.2k
Stanley D. Rosenberg United States 43 1.2k 0.6× 1.2k 0.8× 567 0.6× 237 0.3× 4.5k 6.2× 106 7.0k
Patrick Peretti‐Watel France 36 1.2k 0.6× 617 0.4× 1.2k 1.3× 289 0.3× 505 0.7× 151 4.4k
Claire E. Sterk United States 33 1.5k 0.7× 1.5k 1.0× 1.1k 1.1× 412 0.4× 664 0.9× 119 3.4k
Michelle Teti United States 25 522 0.3× 797 0.6× 835 0.9× 427 0.5× 667 0.9× 110 2.5k
Pamela Jackson United States 27 242 0.1× 1.2k 0.8× 993 1.0× 588 0.6× 793 1.1× 59 3.6k
Douglas Longshore United States 40 3.1k 1.6× 2.0k 1.4× 1.6k 1.7× 770 0.8× 1.2k 1.7× 140 6.3k
Phoenix K. H. Mo Hong Kong 38 791 0.4× 1.3k 0.9× 1.5k 1.6× 328 0.3× 1.3k 1.7× 199 4.7k

Countries citing papers authored by Suzanne Fraser

Since Specialization
Citations

This map shows the geographic impact of Suzanne Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Fraser more than expected).

Fields of papers citing papers by Suzanne Fraser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Fraser. The network helps show where Suzanne Fraser may publish in the future.

Co-authorship network of co-authors of Suzanne Fraser

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Fraser. A scholar is included among the top collaborators of Suzanne Fraser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Fraser. Suzanne Fraser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Moore, David, Suzanne Fraser, Adrian Farrugia, et al.. (2023). Countering ‘the moral science of biopolitics’: Understanding hepatitis C treatment ‘non‐compliance’ in the antiviral era. Sociology of Health & Illness. 46(3). 399–417. 3 indexed citations
3.
Seear, Kate, et al.. (2023). The trouble with normalisation: Transformations to hepatitis C health care and stigma in an era of viral elimination. Sociology of Health & Illness. 45(7). 1421–1440. 6 indexed citations
4.
Seear, Kate, et al.. (2023). Performing Hepatitis C, Problematising “Cure”: The Construction of Hepatitis C (Cure) in Social Security and Migration Law. Law & Literature. 37(1). 113–138. 1 indexed citations
5.
valentine, kylie, et al.. (2023). Hepatitis C data justice: the implications of data-driven approaches to the elimination of hepatitis C. Critical Public Health. 33(5). 803–813. 1 indexed citations
6.
Farrugia, Adrian, et al.. (2023). 'We've got a present for you’: Hepatitis C elimination, compromised healthcare subjects and treatment as a gift. Social Science & Medicine. 340. 116416–116416. 4 indexed citations
7.
Seear, Kate, et al.. (2022). Echoes and Antibodies: Legal Veridiction and the Emergence of the Perpetual Hepatitis C Subject. Social & Legal Studies. 32(2). 216–236. 6 indexed citations
8.
Shaw, Frances, Renae Fomiatti, Adrian Farrugia, & Suzanne Fraser. (2022). Proper distance in the age of social distancing: Hepatitis C treatment, telehealth and questions of care and responsibility. Sociology of Health & Illness. 45(1). 19–36. 6 indexed citations
9.
Seear, Kate, et al.. (2022). Complicating cure: How Australian criminal law shapes imagined post‐hepatitis C futures. Sociology of Health & Illness. 45(1). 179–195. 4 indexed citations
10.
Neale, Joanne, Adrian Farrugia, Aimee Campbell, et al.. (2021). Understanding preferences for type of take-home naloxone device: international qualitative analysis of the views of people who use opioids. Drugs Education Prevention and Policy. 29(2). 109–120. 11 indexed citations
11.
Fomiatti, Renae, David Moore, & Suzanne Fraser. (2017). Interpellating recovery: The politics of ‘identity’ in recovery-focused treatment. International Journal of Drug Policy. 44. 174–182. 60 indexed citations
12.
Farrugia, Adrian, Kate Seear, & Suzanne Fraser. (2017). Authentic advice for authentic problems? Legal information in Australian classroom drug education. Addiction Research & Theory. 26(3). 193–204. 10 indexed citations
13.
Seear, Kate, Suzanne Fraser, David Moore, & Dean Murphy. (2015). Understanding and responding to anabolic steroid injecting and hepatitis C risk in Australia: A research agenda. Drugs Education Prevention and Policy. 22(5). 449–455. 23 indexed citations
14.
Fraser, Suzanne, Robyn Dwyer, Kane Race, et al.. (2011). The Drug Effect. Cambridge University Press eBooks. 63 indexed citations
15.
Fraser, Suzanne. (2010). Hepatitis C and the limits of medicalisation and biological citizenship for people who inject drugs. Addiction Research & Theory. 18(5). 544–556. 15 indexed citations
16.
Fraser, Suzanne, et al.. (2009). Guest Introduction: Living Drugs. Science as Culture. 18. 123–131. 5 indexed citations
17.
Fraser, Suzanne, Max Hopwood, Annie Madden, & Carla Treloar. (2008). ‘Towards a Global Approach’–An overview of Harm Reduction 2008: IHRA’s 19th International Conference. International Journal of Drug Policy. 20(1). 93–97. 2 indexed citations
18.
Fraser, Suzanne & kylie valentine. (2005). Gendered Ethnographies: Researching Drugs, Violence and Gender in New York. Australian Feminist Studies. 20(46). 121–124. 2 indexed citations
19.
Fraser, Suzanne. (2003). The Regulation of Gender: Silicone Breast Implants, Regulatory Processes and Femininity. NOVA (University of Newcastle, Australia). 7. 43–61. 1 indexed citations
20.
Fraser, Suzanne. (2001). 'Woman-Made Women': Mobilisations of Nature in Feminist Accounts of Cosmetic Surgery. Hecate. 27(2). 115–132. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil McKeganey Breakdown of academic impact, for papers by Joanne Neale Breakdown of academic impact, for papers by Faye S. Taxman Breakdown of academic impact, for papers by Stanley D. Rosenberg Breakdown of academic impact, for papers by Patrick Peretti‐Watel Breakdown of academic impact, for papers by Claire E. Sterk Breakdown of academic impact, for papers by Michelle Teti Breakdown of academic impact, for papers by Pamela Jackson Breakdown of academic impact, for papers by Douglas Longshore Breakdown of academic impact, for papers by Phoenix K. H. Mo
Rankless by CCL
2026